Hims & Hers Health Inc (NYSE: HIMS) is 165.06% higher on its value in year-to-date trading and has touched a low of $5.65 and a high of $25.74 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HIMS stock was last observed hovering at around $23.05 in the last trading session, with the day’s gains setting it 0.54%.
Currently trading at $23.59, the stock is 19.84% and 36.64% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.39 million and changing 2.34% at the moment leaves the stock 48.88% off its SMA200. HIMS registered 293.17% gain for a year compared to 6-month gain of 91.32%. The firm has a 50-day simple moving average (SMA 50) of $17.1114 and a 200-day simple moving average (SMA200) of $15.7684.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 43.49% loss in the last 1 month and extending the period to 3 months gives it a 4.80%, and is 3.46% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.15% over the week and 6.19% over the month.
Hims & Hers Health Inc (HIMS) has around 1046 employees, a market worth around $5.11B and $1.07B in sales. Current P/E ratio is 315.37 and Fwd P/E is 31.74. Profit margin for the company is 1.70%. Distance from 52-week low is 317.52% and -8.35% from its 52-week high. The company has generated returns on investments over the last 12 months (4.87%).
The EPS is expected to grow by 394.32% this year.
Hims & Hers Health Inc (HIMS) Top Institutional Holders
416.0 institutions hold shares in Hims & Hers Health Inc (HIMS), with institutional investors hold 75.94% of the company’s shares. The shares outstanding are 205.10M, and float is at 173.93M with Short Float at 14.24%. Institutions hold 66.84% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 16.47 million shares valued at $332.55 million. The investor’s holdings represent 7.7166% of the HIMS Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 14.57 million shares valued at $$294.25 million to account for 6.8278 of the shares outstanding. The other top investors are RENAISSANCE TECHNOLOGIES LLC which holds 6.04 million shares representing 2.8294% and valued at over $121.94 million, while STATE STREET CORP holds 2.0709 of the shares totaling 4.42 million with a market value of $89.25 million.
Hims & Hers Health Inc (HIMS) Insider Activity
The most recent transaction is an insider sale by Chi Michael, the company’s Chief Commercial Officer. SEC filings show that Chi Michael sold 7,500 shares of the company’s common stock on Oct 21 ’24 at a price of $22.20 per share for a total of $0.17 million. Following the sale, the insider now owns 0.19 million shares.
Still, SEC filings show that on Oct 15 ’24, Boughton Soleil (Chief Legal Officer) disposed off 2,339 shares at an average price of $20.41 for $47739.0. The insider now directly holds 172,274 shares of Hims & Hers Health Inc (HIMS).
